Onkologie und Hämatologie | Zeitschrift memo - Magazine of European Medical Oncology Ausgabe 1/2015 Inhaltsverzeichnis ( 18 Artikel ) 01.04.2015 | editorial | Ausgabe 1/2015 Multiple myeloma: the biology, the clinic, and the future Priv. Doz. Dr. Niklas Zojer 01.04.2015 | editorial | Ausgabe 1/2015 Lymphoma: anything new? Eberhard Gunsilius MD 01.04.2015 | review | Ausgabe 1/2015 Is dosing in oncology gender-sensitive? Christine Marosi MD 01.04.2015 | short review | Ausgabe 1/2015 Tailoring treatment in myeloma: are there clues from biology? Priv. Doz. Dr. Niklas Zojer, Heinz Ludwig 01.04.2015 | original report | Ausgabe 1/2015 New drugs on the horizon. Treatment of myeloma in 2020, a perspective Prof. Dr. Heinz Ludwig, Wolfgang Hilbe, Niklas Zojer 01.04.2015 | short review | Ausgabe 1/2015 Is more better in myeloma? Treatment intensity and outcome in newly diagnosed myeloma patients Michael Fillitz, Adelheid Seebacher, Michael Panny 01.04.2015 | short review | Ausgabe 1/2015 To maintain or not to maintain: treatment forever in myeloma? Wolfgang Willenbacher MD, Ella Willenbacher MD 01.04.2015 | short review | Ausgabe 1/2015 Treatment of myeloma patients with renal impairment Daniel Lechner 01.04.2015 | case report | Ausgabe 1/2015 High-dose chemotherapy and autologous hematopoietic stem cell transplantation in a myeloma patient with terminal renal failure and hepatitis C with high viral load Priv. Doz. Dr. Niklas Zojer, Michael Gschwantler, Wolfgang Hilbe 01.04.2015 | short review | Ausgabe 1/2015 Clinical update: B-cell receptor kinase inhibitors in chronic lymphocytic leukemia Lukas Weiss MD, PhD, Thomas Melchardt MD, Alexander Egle MD 01.04.2015 | short review | Ausgabe 1/2015 PET in lymphoma: who, when, how often, pitfalls? Christian Uprimny MD 01.04.2015 | short review | Ausgabe 1/2015 Beyond R-CHOP: treatment of double hit, tripple hit, MYC + NHL? Michael A. Fridrik MD 01.04.2015 | short review | Ausgabe 1/2015 A critical update on prognostic and predictive biomarkers in malignant pleural mesothelioma Bahil Ghanim MD, Mir Alireza Hoda MD, Thomas Klikovits MD, Balazs Dome MD, PhD, Michael Grusch PhD, Martin Filipits PhD, Walter Klepetko MD, Walter Berger PhD, Balazs Hegedus PhD 01.04.2015 | short review | Ausgabe 1/2015 Optimal follow-up of ovarian cancer patients Eduard Vrdoljak MD, PhD, Branka Petrić Miše MD, Tihana Boraska Jelavić MD, PhD, Snježana Tomić MD, PhD, Dinka Šundov MD, PhD, Ante Strikić MD 01.04.2015 | short review | Ausgabe 1/2015 Optimal follow-up of endometrial cancer patients Eduard Vrdoljak MD, PhD, Tihana Boraska Jelavić MD, PhD, Branka Petrić Miše MD, PhD 01.04.2015 | short review | Ausgabe 1/2015 Optimal follow-up of cervical cancer patients Eduard Vrdoljak MD, PhD, Tihana Boraska Jelavić MD, PhD, Branka Petrić Miše MD, PhD, Tomislav Omrčen MD, PhD 01.04.2015 | review | Ausgabe 1/2015 Radiotherapy for brain metastases: are we getting better? Dr. Leor Zach MD, Dr. Alisa Talianski MD, Dr. Yaakov Richard Lawrence MBBS, MA, MRCP 01.04.2015 | review | Ausgabe 1/2015 Predicting drug sensitivity by 3D cell culture models Arno Amann MD, Gabriele Gamerith MD, Julia M. Huber PhD, Marit Zwierzina MD, Wolfgang Hilbe MD, Heinz Zwierzina MD
